Ceftazidime/Avibactam and Meropenem/Vaborbactam for the Management of Enterobacterales Infections: A Narrative Review, Clinical Considerations, and Expert Opinion
This comprehensive review examines the unique attributes, distinctions, and clinical implications of ceftazidime–avibactam (CAZ-AVI) and meropenem–vaborbactam (MEM-VAB) against difficult-to-treat <i>Enterobacterales</i> infections. Our manuscript explores these antibiotics’ pharmacokinetic and pharm...
שמור ב:
| Principais autores: | , , , , , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
MDPI AG
2023-10-01
|
| סדרה: | Antibiotics |
| נושאים: | |
| גישה מקוונת: | https://www.mdpi.com/2079-6382/12/10/1521 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
